Chimeric RNA in Cancer and Stem Cell Differentiation

Gene fusions are considered hallmarks of cancer which can be produced by chromosomal rearrangements. These DNA-level fusion events may result in the expression of chimeric RNAs; however, chimeric RNAs can be also produced by intergenic splicing events. Chimeric transcripts created by the latter mech...

Full description

Saved in:
Bibliographic Details
Main Authors: Justin Elfman, Hui Li
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2018/3178789
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548932708728832
author Justin Elfman
Hui Li
author_facet Justin Elfman
Hui Li
author_sort Justin Elfman
collection DOAJ
description Gene fusions are considered hallmarks of cancer which can be produced by chromosomal rearrangements. These DNA-level fusion events may result in the expression of chimeric RNAs; however, chimeric RNAs can be also produced by intergenic splicing events. Chimeric transcripts created by the latter mechanism are regulated at the transcriptional level and thus present additional modes of action and regulation. They have demonstrated importance in normal cell physiology, and their dysregulation can induce oncogenesis and impact cell differentiation. In this review, we outline proven mechanisms through which intergenically spliced chimeric RNAs are involved in carcinogenesis. We highlight their similarity to canonical chimeric RNAs resulting from gene fusions as well as their unique qualities. Additionally, we review known roles of chimeric RNA in cell differentiation and propose means through which chimeric RNAs may be valuable as stage-specific markers or as targets for expression profiling.
format Article
id doaj-art-09d40bb7dad443eba324217203824722
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-09d40bb7dad443eba3242172038247222025-02-03T06:12:37ZengWileyStem Cells International1687-966X1687-96782018-01-01201810.1155/2018/31787893178789Chimeric RNA in Cancer and Stem Cell DifferentiationJustin Elfman0Hui Li1Department of Biochemistry and Molecular Genetics, University of Virginia, 22903, USADepartment of Biochemistry and Molecular Genetics, University of Virginia, 22903, USAGene fusions are considered hallmarks of cancer which can be produced by chromosomal rearrangements. These DNA-level fusion events may result in the expression of chimeric RNAs; however, chimeric RNAs can be also produced by intergenic splicing events. Chimeric transcripts created by the latter mechanism are regulated at the transcriptional level and thus present additional modes of action and regulation. They have demonstrated importance in normal cell physiology, and their dysregulation can induce oncogenesis and impact cell differentiation. In this review, we outline proven mechanisms through which intergenically spliced chimeric RNAs are involved in carcinogenesis. We highlight their similarity to canonical chimeric RNAs resulting from gene fusions as well as their unique qualities. Additionally, we review known roles of chimeric RNA in cell differentiation and propose means through which chimeric RNAs may be valuable as stage-specific markers or as targets for expression profiling.http://dx.doi.org/10.1155/2018/3178789
spellingShingle Justin Elfman
Hui Li
Chimeric RNA in Cancer and Stem Cell Differentiation
Stem Cells International
title Chimeric RNA in Cancer and Stem Cell Differentiation
title_full Chimeric RNA in Cancer and Stem Cell Differentiation
title_fullStr Chimeric RNA in Cancer and Stem Cell Differentiation
title_full_unstemmed Chimeric RNA in Cancer and Stem Cell Differentiation
title_short Chimeric RNA in Cancer and Stem Cell Differentiation
title_sort chimeric rna in cancer and stem cell differentiation
url http://dx.doi.org/10.1155/2018/3178789
work_keys_str_mv AT justinelfman chimericrnaincancerandstemcelldifferentiation
AT huili chimericrnaincancerandstemcelldifferentiation